FDA Authorizes First At-Home COVID-19 Sample Collection Kit
Posted on Apr 21, 2020 07:02 pm
The U.S. Food and Drug Administration announced its approval of Laboratory Corporation of America’s (LabCorp) COVD-19 RT-RCR Test to facilitate home testing for coronavirus.
“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” said FDA Commissioner Stephen M. Hahn in a press release. Hahn added that LabCorp’s test demonstrated “safe and accurate” results for home testing.
Tests will be available in the coming weeks and will require a doctor’s order.
Patients will collect a specimen using a specific Q-tip-style cotton swab and mail the sample back to LabCorp for testing. “It is important to note that this is not a general authorization for at-home collection of patient samples using other collection swabs, media, or tests, or for tests fully conducted at home,” according the agency.
Photo by AP Photo/David Goldman
Post courtesy of the Association of Defense Communities